David Shaw’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-7,200
Closed -$522K – 4449
2025
Q1
$522K Buy
+7,200
New +$515K ﹤0.01% 3484
2023
Q1
– Sell
-42,800
Closed -$3.19M – 4561
2022
Q4
$3.19M Hold
42,800
– – ﹤0.01% 2528
2022
Q3
$3.54M Buy
+42,800
New +$4.12M ﹤0.01% 2456
2021
Q1
– Sell
-88,200
Closed -$8.05M – 4170
2020
Q4
$8.05M Hold
88,200
– – 0.01% 1511
2020
Q3
$7.04M Hold
88,200
– – 0.01% 1462
2020
Q2
$6.1M Sell
88,200
-5,100
-5% -$362K 0.01% 1515
2020
Q1
$5.87M Sell
93,300
-21,300
-19% -$1.54M 0.01% 1349
2019
Q4
$8.91M Buy
114,600
+22,200
+24% +$1.73M 0.01% 1282
2019
Q3
$6.77M Buy
+92,400
New +$6.49M 0.01% 1423
2016
Q1
– Sell
-60,000
Closed -$1.58M – 3526
2015
Q4
$1.58M Hold
60,000
– – ﹤0.01% 2315
2015
Q3
$1.42M Hold
60,000
– – ﹤0.01% 2348
2015
Q2
$1.42M Sell
60,000
-67,200
-53% -$1.52M ﹤0.01% 2449
2015
Q1
$3.02M Sell
127,200
-4,200
-3% -$94.2K ﹤0.01% 1729
2014
Q4
$2.79M Hold
131,400
– – ﹤0.01% 1998
2014
Q3
$2.24M Hold
131,400
– – ﹤0.01% 2155
2014
Q2
$1.88M Sell
131,400
-226,800
-63% -$3.07M ﹤0.01% 2360
2014
Q1
$4.43M Sell
358,200
-3,000
-0.8% -$34.6K 0.01% 1694
2013
Q4
$3.96M Buy
361,200
+139,800
+63% +$1.58M 0.01% 1897
2013
Q3
$2.57M Buy
+221,400
New +$2.59M ﹤0.01% 2208

Other funds holding EW

David Shaw's EW Position: Q3 2026 in Review

David Shaw opened a new position in Edwards Lifesciences (EW) in Q3 2026: 4,045 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #4427 among its holdings. This is a return to the name: David Shaw previously reported a position in EW as recently as Q4 2025.

David Shaw first reported a position in EW in Q2 2013 and has held it in 46 quarters since. The position peaked at $251M in Q1 2023. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • David Shaw held 4,045 shares of Edwards Lifesciences worth $349K as of Q3 2026.
  • Edwards Lifesciences was a new David Shaw position in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4427 holding.
  • David Shaw first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 46 quarters since.
  • David Shaw's Edwards Lifesciences position peaked at $251M in Q1 2023.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.